These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9933449)

  • 1. Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologically.
    Mohamood AS; Guler ML; Xiao Z; Zheng D; Hess A; Wang Y; Yagita H; Schneck JP; Hamad AR
    Am J Pathol; 2007 Jul; 171(1):97-106. PubMed ID: 17591957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-12-secreting fibroblasts are more efficient than free recombinant interleukin-12 in inducing the persistent resistance to Mycobacterium avium complex infection.
    Kang BY; Chung SW; Lim YS; Kim EJ; Kim SH; Hwang SY; Kim TS
    Immunology; 1999 Jul; 97(3):474-80. PubMed ID: 10447770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbial Antigenic Mimicry in Autoimmunity.
    Garabatos N; Santamaria P
    Front Immunol; 2022; 13():873607. PubMed ID: 35572569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the Causal Role of Gut Microbiota in Type 1 Diabetes and Its Possible Pathogenic Mechanisms.
    Zhou H; Sun L; Zhang S; Zhao X; Gang X; Wang G
    Front Endocrinol (Lausanne); 2020; 11():125. PubMed ID: 32265832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the immune system by the gut microbiota in the development of type 1 diabetes.
    Pearson JA; Agriantonis A; Wong FS; Wen L
    Hum Vaccin Immunother; 2018; 14(11):2580-2596. PubMed ID: 30156993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention or acceleration of type 1 diabetes by viruses.
    Ghazarian L; Diana J; Simoni Y; Beaudoin L; Lehuen A
    Cell Mol Life Sci; 2013 Jan; 70(2):239-55. PubMed ID: 22766971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant immunotherapy of experimental autoimmune encephalomyelitis: immature myeloid cells expressing CXCL10 and CXCL16 attract CXCR3+CXCR6+ and myelin-specific T cells to the draining lymph nodes rather than the central nervous system.
    O'Connor RA; Li X; Blumerman S; Anderton SM; Noelle RJ; Dalton DK
    J Immunol; 2012 Mar; 188(5):2093-101. PubMed ID: 22287719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions.
    King C; Sarvetnick N
    PLoS One; 2011 Feb; 6(2):e17049. PubMed ID: 21364875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review series on helminths, immune modulation and the hygiene hypothesis: how might infection modulate the onset of type 1 diabetes?
    Cooke A
    Immunology; 2009 Jan; 126(1):12-7. PubMed ID: 19120494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria.
    Clatworthy MR; Willcocks L; Urban B; Langhorne J; Williams TN; Peshu N; Watkins NA; Floto RA; Smith KG
    Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7169-74. PubMed ID: 17435165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection.
    Saunders KA; Raine T; Cooke A; Lawrence CE
    Infect Immun; 2007 Jan; 75(1):397-407. PubMed ID: 17043101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis.
    Sewell DL; Reinke EK; Co DO; Hogan LH; Fritz RB; Sandor M; Fabry Z
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):564-72. PubMed ID: 12853387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of Mycobacterium avium-induced resistance against insulin-dependent diabetes mellitus (IDDM) in non-obese diabetic (NOD) mice: role of Fas and Th1 cells.
    Martins TC; Aguas AP
    Clin Exp Immunol; 1999 Feb; 115(2):248-54. PubMed ID: 9933449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for CD45RBlow CD38+ T cells and costimulatory pathways of T-cell activation in protection of non-obese diabetic (NOD) mice from diabetes.
    Martins TC; Aguas AP
    Immunology; 1999 Apr; 96(4):600-5. PubMed ID: 10233747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in B and T lymphocytes associated with mycobacteria-induced protection of NOD mice from diabetes.
    Martins TC; Aguas AP
    J Autoimmun; 1996 Aug; 9(4):501-7. PubMed ID: 8864825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
    Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
    J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
    Greil R; Egle A; Villunger A
    Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta cell destruction in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse.
    Thomas HE; Kay TW
    Diabetes Metab Res Rev; 2000; 16(4):251-61. PubMed ID: 10934453
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.